One of the major challenges of the post-authorization stage is the data. Data in this phase comes from multiple sources, is often recorded manually, and is not always easy to interpret. We work with AI tools that enable us to translate any format, and have experienced linguists working in 330+ language combinations.
Timing is absolutely of the essence in this phase, especially in the case of rare adverse events reporting. We implement our linguist allocation and efficiency tools to rapidly translate and review this highly time-sensitive content.
The sheer volume of information and the human resources required to parse said information are major challenges, as are the costs that come with that resourcing. Our clients give us their multilingual data, so we can apply custom workflows and AI tools to deliver fast, accurate translations at scale.
The key to this entire phase is to maintain lines of clear communication across all stakeholder groups, especially when communicating findings back to HCPs and the public. Information must be conveyed in a way that is clear, ensures safety, and avoids misinterpretation. Which is where having access to our trained linguists on the ground in 110 countries becomes a major asset for our clients.
